Plimoth Trust CO LLC Novartis Ag Transaction History

Plimoth Trust CO LLC

$383 Million
Q4 2024

A detailed history of Plimoth Trust CO LLC transactions in Novartis Ag stock. As of the latest transaction made, Plimoth Trust CO LLC holds 2,148 shares of NVS stock, worth $226,463. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,148

Previous 2,148 -0.0%

Holding current value

$226,463

Previous $247,000 15.38%

% of portfolio

0.05%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$106.13 - $120.89 $227,967 - $259,671	2,148 New	2,148 $247,000
Q2 2022 Jul 15, 2022	SELL	$80.52 - $93.75 $14,252 - $16,593	-177 Reduced 5.91%	2,820 $239,000
Q1 2022 Apr 25, 2022	SELL	$80.11 - $90.62 $2,162 - $2,446	-27 Reduced 0.89%	2,997 $263,000
Q4 2021 Jan 27, 2022	SELL	$79.7 - $88.13 $6,376 - $7,050	-80 Reduced 2.58%	3,024 $265,000
Q3 2021 Oct 22, 2021	SELL	$81.78 - $95.14 $16,764 - $19,503	-205 Reduced 6.2%	3,104 $254,000
Q2 2021 Jul 20, 2021	SELL	$85.24 - $94.15 $1,704 - $1,883	-20 Reduced 0.6%	3,309 $302,000
Q1 2021 Apr 14, 2021	SELL	$83.5 - $98.47 $56,780 - $66,959	-680 Reduced 16.96%	3,329 $284,000
Q4 2020 Jan 22, 2021	SELL	$78.07 - $94.43 $87,672 - $106,044	-1,123 Reduced 21.88%	4,009 $378,000
Q3 2020 Oct 27, 2020	SELL	$82.14 - $91.0 $54,212 - $60,060	-660 Reduced 11.4%	5,132 $446,000
Q2 2020 Jul 20, 2020	SELL	$80.93 - $91.1 $78,178 - $88,002	-966 Reduced 14.29%	5,792 $505,000
Q1 2020 Apr 22, 2020	SELL	$70.67 - $99.01 $90,457 - $126,732	-1,280 Reduced 15.92%	6,758 $558,000
Q4 2019 Jan 29, 2020	SELL	$84.35 - $95.37 $75,324 - $85,165	-893 Reduced 10.0%	8,038 $761,000
Q3 2019 Oct 28, 2019	SELL	$85.54 - $94.26 $78,269 - $86,247	-915 Reduced 9.29%	8,931 $776,000
Q2 2019 Aug 05, 2019	SELL	$75.4 - $92.8 $135,343 - $166,576	-1,795 Reduced 15.42%	9,846 $899,000
Q1 2019 Apr 19, 2019	SELL	$75.32 - $86.15 $84,283 - $96,401	-1,119 Reduced 8.77%	11,641 $1.12 Million
Q4 2018 Jan 25, 2019	SELL	$73.66 - $82.02 $70,860 - $78,903	-962 Reduced 7.01%	12,760 $1.1 Million
Q3 2018 Dec 13, 2018	SELL	$66.94 - $77.43 $101,079 - $116,919	-1,510 Reduced 9.91%	13,722 $1.18 Million
Q2 2018 Dec 12, 2018	SELL	$64.91 - $73.36 $190,835 - $215,678	-2,940 Reduced 16.18%	15,232 $1.15 Million
Q1 2018 Dec 21, 2018	SELL	$70.39 - $84.15 $34,631 - $41,401	-492 Reduced 2.64%	18,172 $1.47 Million
Q4 2017 Dec 26, 2018	BUY	$72.33 - $77.64 $1.35 Million - $1.45 Million	18,664	18,664 $1.57 Million

Others Institutions Holding NVS

# of Institutions

1,468

Shares Held

134M

Call Options Held

1.4M

Put Options Held

1.61M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Plimoth Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plimoth Trust CO LLC with notifications on news.

Account

Plimoth Trust CO LLC Novartis Ag Transaction History